- TTPH has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $9.4 million.
- TTPH has traded 5,591 shares today.
- TTPH is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in TTPH with the Ticky from Trade-Ideas. See the FREE profile for TTPH NOW at Trade-Ideas More details on TTPH: Tetraphase Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multi-drug resistant infections. Currently there are 6 analysts that rate Tetraphase Pharmaceuticals a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Tetraphase Pharmaceuticals has been 294,200 shares per day over the past 30 days. Tetraphase has a market cap of $458.6 million and is part of the health care sector and drugs industry. Shares are up 31.1% year-to-date as of the close of trading on Friday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. TheStreetRatings.com Analysis: TheStreet Quant Ratings rates Tetraphase Pharmaceuticals as a sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income and weak operating cash flow.